Willy P. Burkard - Concepedia

Author

Willy P. Burkard

Roche (Switzerland)

Also Known As

Willy Burkard, Willy P. Burkard

Publications

535

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)University of Basel Universität Innsbruck

About

Willy P. Burkard is an author at Roche (Switzerland) specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	329
2	Biochemistry	3	3	61
3	Natural Sciences	2	2	108
4	Social Sciences	2	2	104
5	Health Sciences	1	1	40

Willy P. Burkard

Publications

505

Citations

H-Index

Page 1

	Year	Citations
Inhibition of benzodiazepine binding in vitro by amentoflavone, a constituent of various species of Hypericum Karl H. Baureithel, Karin Berger Büter, Anja Engesser, Pharmaceutica Acta Helvetiae Medicinal ChemistryMedicineHerb-drug InteractionBenzodiazepine BindingPhytopharmacology	1997	105
Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol E. P. Bonetti, Willy P. Burkard, M. Gabl, Pharmacology Biochemistry and Behavior Partial Inverse AgonismNatural SciencesMolecular BiologyComputational ChemistryQuantum Chemistry	1988	93
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(Cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective .mu. opioid receptor antagonist Helmut Schmidhammer, Willy P. Burkard, Lislott Eggstein‐Aeppli, Journal of Medicinal Chemistry	1989	83
Histamine H2-receptor binding with 3H-cimetidine in brain Willy P. Burkard European Journal of Pharmacology NeurophysiologyMedicineNeurotransmitterNeuropharmacologyNeuroscience	1978	78
Verapamil, an antagonist at 5-Hydroxytryptamine receptors of human blood platelets Hubert Affolter, Willy P. Burkard, A. Pletscher European Journal of Pharmacology ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletMedicine	1985	40
The benzodiazepine antagonist Ro 15–1788 reverses the effect of methyl-β-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in mice Willy P. Burkard, E. P. Bonetti, W. Haefely European Journal of Pharmacology Molecular PharmacologyNeurophysiologyMedicineCerebellar CgmpNeuropharmacology	1985	26
Harmaline and its sulfur analogue: Increase of cerebellar cyclic GMP and inhibition of monoamine oxidase Willy P. Burkard, R. Kettler Biochemical Pharmacology NeuropeptidesBiochemistryMedicineSulfur AnalogueNeurotransmitter	1977	24
(−)‐<i>N</i>‐[(Cyclopropyl) methyl]‐3,4‐dimethoxy‐5‐methylmorphinan‐6‐one, an opioid agonist with preference for kappa opioid receptors Helmut Schmidhammer, Florian Fritsch, Willy P. Burkard, Helvetica Chimica Acta Opioid EpidemicMolecular PharmacologyEssential IntermediatePharmaceutical ChemistryBiochemistry	1988	22
Hypericum perforatum inhibits the binding of μ- and κ-opioid receptor expressed with the Semliki Forest virus system Urs Simmen, Christophe Schweitzer, Willy P. Burkard, Pharmaceutica Acta Helvetiae Molecular PharmacologyHypericum PerforatumMedicineImmunologyNeuropharmacology	1998	19
Über die Wirkung von symmetrischen 1,2‐Dialkylhydrazinen auf Carbonylverbindungen und Amin‐oxydasen. 16. Mitteilung über Amin‐oxydasen John Carbon, Willy P. Burkard, E. A. Zeller Helvetica Chimica Acta Pi 50Auf CarbonylverbindungenOrganic ChemistryChemistryChemical Biology	1958	15

Page 1